Company intelligence / Profile preview

Bone Index Finland Ltd.

Kuopio, Northern Savo / Eastern Finland, Finlandbindex.fi ↗

Ownership: Private
Employees: ~8
Development stage: Commercial

Overview

Bindex®, the company’s flagship product, has been proven through research and practice to be an efficient and accurate instrument in osteoporosis diagnostics. It enables rapid point-of-care assessment of bone mineral density comparable to DXA scans and supports evidence-based treatment decisions. The device has been used in large-scale population screenings and aims to improve early detection rates for osteoporosis globally

Therapeutic areas: EndocrinologyRheumatology
Modalities: DeviceDiagnostic device
Industry: Medical Imaging

Partnerships

Lynx Financial (strategic investment/expansion partnership)Suomen Terveystalo (Finland’s largest private healthcare provider; partnered for large-scale screening project)

Beyond the preview

Go deeper on Bone Index Finland Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bone Index Finland Ltd..

Explore the full profile